Onyia Jude Insider Trades

Insider Trading History

Track insider trading activity for Onyia Jude. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Voyager Therapeutics
Voyager Therapeutics VYGR
Director
Holding Value $94.8k 30,000 shares
Last Trade
Jun 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$103k 30,000 shares
$3.43
$3.16
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Scientific Officer
Holding Value $4.03M 23,405 shares
Last Trade
Jun 05, 2026 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$400k 2,441 shares
$163.88
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Scientific Officer
Holding Value $4.45M 25,846 shares
Last Trade
Jun 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.76M 11,000 shares
$160.25
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Scientific Officer
Holding Value $2.28M 13,268 shares
Last Trade
Jun 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.77M 11,000 shares
$161.00
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Scientific Officer
Holding Value $6.34M 36,846 shares
Last Trade
Jun 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.77M 11,000 shares
$161.00
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Scientific Officer
Holding Value $6.34M 36,846 shares
Last Trade
May 27, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.71M 11,000 shares
$155.83
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Scientific Officer
Holding Value $4.18M 24,268 shares
Last Trade
May 27, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.71M 11,000 shares
$155.83
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Scientific Officer
Holding Value $4.45M 25,846 shares
Last Trade
May 27, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.71M 11,000 shares
$155.53
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Scientific Officer
Holding Value $4.42M 25,670 shares
Last Trade
Feb 20, 2026 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$400k 3,110 shares
$128.63
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Scientific Officer
Holding Value $926k 5,380 shares
Last Trade
Feb 13, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$670k 5,407 shares
$124.00
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Scientific Officer
Holding Value $4.95M 28,780 shares
Last Trade
Feb 13, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.7M 13,673 shares
$124.12
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Scientific Officer
Holding Value $9.48M 55,119 shares
Last Trade
Feb 13, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.5M 84,723 shares
$124.00
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Scientific Officer
Holding Value $3.62M 21,066 shares
Last Trade
Feb 13, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$670k 5,407 shares
$124.00
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Scientific Officer
Holding Value $1.32M 7,681 shares
Last Trade
Feb 12, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$315k 2,560 shares
$123.10
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Scientific Officer
Holding Value $2.94M 17,111 shares
Last Trade
Feb 12, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$176k 1,426 shares
$123.10
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Scientific Officer
Holding Value $3.19M 18,537 shares
Last Trade
Feb 12, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$315k 2,560 shares
$123.10
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Scientific Officer
Holding Value $2.77M 16,119 shares
Last Trade
Jan 31, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$32.4k 238 shares
$136.06
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Scientific Officer
Holding Value $2.75M 15,977 shares
Last Trade
Jan 31, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$19.3k 142 shares
$136.06
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Scientific Officer
Holding Value $0 0 shares
Last Trade
Jan 31, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$32.4k 238 shares
$136.06
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Scientific Officer
Holding Value $3.12M 18,129 shares
Last Trade
Nov 29, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$673k 4,426 shares
$152.16
$172.04

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up